Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-02

Clinical Trial Update: DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse [Phase 2]

View source ↗

Summary

Phase 2 study evaluating DCEP (dexamethasone, cisplatin, etoposide, cyclophosphamide) in combination with thalidomide as salvage therapy for post-transplant rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • DEXAMETHASONE (Dexamethasone)
  • Etoposide (Etoposide)
  • Thalidomide (thalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED